These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12456222)

  • 1. The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism.
    Dalen JE
    Arch Intern Med; 2002 Dec 9-23; 162(22):2521-3. PubMed ID: 12456222
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.
    Agnelli G; Becattini C; Kirschstein T
    Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis in the treatment of submassive pulmonary embolism.
    Mascitelli L; Pezzetta F
    Arch Intern Med; 2003 May; 163(10):1238; author reply 1238. PubMed ID: 12767964
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating status of thrombolysis in pulmonary embolism.
    Jain N
    Indian Heart J; 2010; 62(1):92. PubMed ID: 21180048
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?
    Worster A; Smith C; Silver S; Brown MD
    Ann Emerg Med; 2007 Jul; 50(1):78-84. PubMed ID: 17449142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy.
    Meneveau N
    Curr Opin Cardiol; 2010 Nov; 25(6):560-7. PubMed ID: 20852415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified thrombolytic therapy for massive pulmonary emboli.
    Arsanjani R; Goldman S; Habib MP; Movahed MR
    Am J Med; 2011 Aug; 124(8):e7-8. PubMed ID: 21658666
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pearls in thrombosis and anticoagulation.
    Merli GJ; Litin SC
    Mayo Clin Proc; 2009 Dec; 84(12):1120-4. PubMed ID: 19955248
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy in pulmonary embolism.
    Goldhaber SZ; Bounameaux H
    Semin Vasc Med; 2001 Nov; 1(2):213-20. PubMed ID: 15199505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism].
    Nielsen HK; Lassen JF; Ravn HB; Husted SE
    Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel.
    Sista AK; Goldhaber SZ; Vedantham S; Kline JA; Kuo WT; Kahn SR; Kabrhel C; McLaughlin VV; White SB; Kim NH; Gray M; Simon MA; Benenati JF; Misra S; Sterling KM; Kee ST; Konstantinides SV; Jaff MR; Kearon C
    J Vasc Interv Radiol; 2016 Jun; 27(6):787-94. PubMed ID: 27287967
    [No Abstract]   [Full Text] [Related]  

  • 16. TIMI Risk Index as a Predictor of 30-Day Outcomes in Patients With Acute Pulmonary Embolism.
    Zuin M; Conte L; Picariello C; Pastore G; Vassiliev D; Lanza D; Zonzin P; Zuliani G; Rigatelli G; Roncon L
    Heart Lung Circ; 2018 Feb; 27(2):190-198. PubMed ID: 28487060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reason to reduce expectations of thrombolytic therapy in pulmonary embolism.
    Lucas S
    BMJ; 2013 Mar; 346():f1690. PubMed ID: 23512455
    [No Abstract]   [Full Text] [Related]  

  • 18. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for acute pulmonary embolism: when do the benefits exceed the risks?
    Stein PD; Dalen JE
    Am J Med; 2014 Nov; 127(11):1031-1032. PubMed ID: 25019361
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.